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Phospholipid membraneThe membrane interaction of the cyclotide kalata B1, an all-D-analogue and a single alanine substituted ana-
logue (G6A), was studied by surface plasmon resonance (SPR) and atomic force microscopy (AFM). Kalata B1
showed a strong binding selectivity for dimyristoyl-phosphatidylethanolamine (DMPE) compared to
dimyristoyl-phoshatidylcholine (DMPC)-containing lipids. However, when the interaction was visualized
by AFM the peptide interacted with DMPC and DMPE in a similar manner. There was no apparent change
in membrane morphology with either lipid, suggesting that kalata B1 does not act via a carpet-like disruption
mechanism. The D-analogue showed similar binding by SPR and the same strong selectivity for DMPE, indi-
cating that the membrane-interaction and lipid selectivity are not stereo-speciﬁc. SPR studies of the G6A an-
alogue revealed that it interacted in a similar way to kalata B1 on the DMPC containing lipids, but showed no
increased response on the DMPE containing lipids observed for kalata B1 and D-kalata B1. These results indi-
cate that the Gly6 residue directly inﬂuences membrane binding as it is located near a putative membrane
interacting hydrophobic patch. Overall, the data suggest that very small changes in amino acid composition
(with no change in conformation) can inﬂuence speciﬁc self-association in combination with membrane
binding and mediate the activity of kalata B1.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cyclotides [1,2] are a family of plant-derived mini-proteins that
comprise around 30 amino acids and are characterised by their dis-
tinct combination of a cyclized backbone (their C and N termini are
linked together via a peptide bond) and six highly conserved cystine
residues that form a knotted arrangement of cross-linking disulﬁde
bonds. The combination of these two structural characteristics
makes cyclotides resistant to enzymatic breakdown and imparts a va-
riety of properties that are attractive for agricultural applications [3]
and as molecular scaffolds for pharmaceutical design [4].
The ﬁrst member of this family to be identiﬁed was kalata B1 [5],
which was discovered through anecdotal reports of its medicinal
use by African women in a tea made from the plant Oldenlandia afﬁnis
(Rubiaceae) to accelerate childbirth [6]. Many cyclotides haveircular dichroism; CHAPS, 3-
onate; DMPC, 1,2-dimyristoyl-
sn-glycero-3-[phospho-rac-(1-
ethanolamine;MIC, minimum
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l rights reserved.now been discovered in species of the Rubiaceae (coffee) [7,8] and
Violaceae (violet) [1,9,10] plant families, with over 200 sequences
reported to date (www.CyBase.org.au). In artiﬁcial feeding trials a
number of cyclotides cause a potent inhibition of growth and devel-
opment of the cotton bollworm and budworm so their primary natu-
ral function appears to be as a host defence in plants against insect
pests [3,11]. In addition to their insecticidal and uterotonic activity,
anti-tumour [12], anti-HIV [7,13], haemolytic [9] and antibacterial
[14] activities have been reported. Kalata B1 has also been reported
to have cytolytic activity against a variety of microbes [14] and is
weakly haemolytic, with 50% red blood cell hemolysis at 1.5 mM
[14].
The mechanism by which cyclotides exert their multiple effects is
currently unknown. There is no evidence that they are receptor medi-
ated and studies have shown that they interact with membranes
[15–17], possibly acting by forming self-associating multimeric spe-
cies [18]. Three dimensional structures have highlighted the exis-
tence of a surface exposed patch of hydrophobic residues that might
be involved in membrane binding [19]. The circular sequence, three di-
mensional structure, and knotted arrangement of the three conserved
disulﬁde bonds of kalata B1 is shown in Fig. 1. Asmentioned previously,
it is this cyclic backbone and the cystine knot that give cyclotides their
resistance to thermal, chemical and enzymatic breakdown compared
to linear peptides of similar size [20]. It is these properties that make
Fig. 1. A) Circular sequence of kalata B1 showing the disulﬁde bonds with intercon-
necting yellow lines between paired cysteine residues (labelled in Roman numerals).
The green star denotes residue 1 and the green arrow indicates the direction of
amino acid residue numbering; B) three dimensional NMR structure of kalata B1 in rib-
bon format showing β-strands as red arrows and the disulﬁde bonds shown in ball and
stick format [23].
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peptide epitopes to create novel peptide drugs [2,4,21].
The binding of kalata peptides to model membranes was ﬁrst
studied using SPR for two naturally occurring cyclotides from O. afﬁnis
[15]. The study revealed that dramatic changes in membrane binding
properties were observed with different lipid mixtures, and both
kalata B1 and kalata B6 showed binding selectivity toward DMPE
lipidmixtures. A later study demonstrated that kalata B1 induces leak-
age in vesicles and pores in model membranes as measured by elec-
trophysiology techniques [17]. Very recently, we reported that an all
D-kalata B1 (comprised of all D-amino acids instead of the naturally
occurring L-amino acids) bound tomodelmembraneswith only slightly
decreased afﬁnity to the natural L-peptide [22]. In the current investiga-
tion, the binding of L- and D-kalata B1was further studied together with
an Ala mutant identiﬁed recently to be inactive in insecticidal assays
[23]. In an alanine scan of kalata B1 the analogue in which Gly was
replaced by Ala at position 6 (G6A) showed a dramatic decrease in
insecticidal activity compared to kalata B1 [23]. In order to explore the
role of membrane binding in the large differences in haemolytic and
insecticidal activity, the binding of kalata B1, D-kalata B1 and the G6A
analogue tomodelmembraneswas studied. The resultswere correlated
with secondary structure and the effects of kalata B1 on membrane
morphology.2. Materials and methods
2.1. Chemicals and reagents
Sodium phosphate dibasic/monobasic, (3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate) (CHAPS), 1,2-dimyris-
toyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (sodium Salt) (DMPG),
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), and
cholesterol, were purchased from Sigma (St Louis, MO, USA). Sodium
Chloride was purchased from Spectrum Chemical (Gardena, CA, USA).
Choloroform and methanol were purchased from Merck (Vic, Australia).Table 1
Sequence and masses of kalata B1 and the G6A analogue.
Peptide Sequence Mr
Kalata B1 GLPVCGETCVGGTCNTPGCTCSWPVCTRN (cyclic) 2892
G6A GLPVCAETCVGGTCNTPGCTCSWPVCTRN (cyclic) 2906Water was quartz-distilled and deionised in a Milli-Q system (Millipore,
Bedford, MA, USA). Kalata B1, D-kalata B1 and G6A were synthesised by
solid phase peptide synthesis, puriﬁed by reversed phase high perfor-
mance liquid chromatography and the correct mass was determined by
electrospray mass spectrometry as previously described [18,22,23]
(Table 1).
2.2. Liposome preparation
DMPC and cholesterol were dissolved in chloroform, DMPG was
dissolved in a mixture of chloroform/methanol (3:1 v/v) and DMPE
was dissolved in a mixture of chloroform/methanol (1:1 v/v) to cre-
ate individual stock solutions. These stock solutions were then ali-
quoted into test tubes in the desired molar ratios: DMPC, DMPC/
DMPG (4:1 v/v), DMPC/DMPG/cholesterol (16:4:5 v/v), DMPE, DMPE/
DMPG (4:1 v/v). The solvent was evaporated under a gentle stream of
N2 and vacuum desiccated overnight. For circular dichroism experi-
ments, lipids were resuspended in 20 mM phosphate buffer with
150 mM NaCl (pH 7.4) with vortexing to a concentration of 1.36 mM.
The resultant lipid dispersionwas then sonicated with a bath type soni-
cator until clear. For surface plasmon resonance experiments, lipids
were resuspended into buffer with vortexing to a concentration of
0.5–1 mM. The lipid dispersion was then sonicated in a bath type soni-
cator until nearly clear. Small unilamellar vesicles (SUV; 50 nm) were
created via extruding the sonicated mixture through a 50 nm poly-
carbonate membrane (Avestin). For AFM experiments, lipids were
resuspended in buffer to a concentration of 0.1–0.5 mM, vortexed and
sonicated brieﬂy before use.
2.3. Circular dichroism (CD)
CD measurements were carried out on a Jasco J-810 Circular Di-
chroism Spectropolariser (Jasco, Tokyo Japan). Using quartz cells of a
1 mm path length, scans between wavelengths of 190 and 260 nm
were done with a scan speed of 20 nm/min and a bandwidth of
1.0 nm. The resolution was 0.1 nmwith a 1 s response time, 5 scan ac-
cumulations. The quartz cell temperaturewas controlledwith a peltier
temperature controller at 25 °C. The CD instrument was calibrated
with (+)-10-camphorsulphonic acid. The different lipid liposomes
were prepared as above. The concentration of these lipids was
1.36 mM. Once the lipid solution was ready, peptide was then added
to a peptide lipid ratio of approximately 1:100. This was then sonicat-
ed brieﬂy just beforemeasurements. The concentration of peptidewas
determined by absorbance at 280 nm (e100=5875 M−1 cm−1). The
same peptide concentration was used for samples with peptide in
the buffer solution alone. The CD spectra were measured for the pep-
tides in the phosphate buffer solution and in the presence of the differ-
ent lipid liposomes. The CD signal resulting from the solvent alonewas
subtracted from the spectrum of each peptide solution. The ﬁnal spec-
tra obtained for each was the average of the 5 scans accumulated.
Spectra were smoothed using the Jasco Fast Fourier transform algo-
rithm and baseline corrected.
2.4. Surface plasmon resonance (SPR)
SPR experiments were carried out with a Biacore 3000 analytical
systemwith an L1 sensor chip (Biacore, Uppsala, Sweden). The system
was cleaned using the ‘Desorb and Sanitize’ protocol with a mainte-
nance chip and then allowed to run overnight with water. The L1
chip was docked and ﬁrst washed with an injection of 5 μl of 20 mM
CHAPS at a ﬂow rate of 5 μl/min to clean the chip surface. SUVs in im-
mobilization buffer (20 mM phosphate buffer 150 mM NaCl pH 7.4)
were then immediately applied to the chip surface with injections of
80 μl at a low ﬂow rate of 2 μl/min. To remove any multi-lamellar
structures from the lipid surface and to stabilize the baseline, 30 μl of
Fig. 2. The CD spectra of kalata B1 in buffer and with different liposomes. 13.6 μM pep-
tide was used with a peptide to lipid ratio of 1:100.
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pared, degassed and ﬁltered through a 0.2 μm ﬁlter.
Peptide solutions were prepared by dissolving each of peptide in
the running buffer (20 mM phosphate buffer 150 mM NaCl pH 7.4),
creating 5 serial dilutions of 10 μM to 50 μM. 100 μl of these solutions
was injected at a ﬂow rate of 30 μl/min having a total injection time of
200 s. On completion of injection, buffer ﬂow continued to allow a
dissociation time of at least 600 s. Buffer-only blank injections were
also made to ensure minimal bulk effects. All binding experiments
were carried out at 25 °C. Kinetic analysis of the sensorgrams, collect-
ed from peptide injections at different concentrations over each dif-
ferent lipid surface, was performed using the Langmuir, the parallel
and the two state curve ﬁtting models as described in previous
[15,24–26] investigations for other peptide–membrane interactions
2.5. Atomic force microscopy (AFM)
AFM experiments were performed on a Multimode/Nanoscope IV
AFM (Digital Instruments, CA, USA) using a vertical engage ‘E’ scan-
ner. Images were performed in buffer via taping mode with NSC-36
‘B’ silicon cantilevers (Micromasch, Tallinn, Estonia) with a nominal
force constant of 1.75 N/m. 20 μl of freshly prepared lipid solution
was deposited onto freshly cleaved mica that had been glued to a
metal disc, this was then heated to 40 °C to assist fusion of vesicles
on the surface. After 30 minutes incubation, the sample surface was
rinsed 3 times with buffer. The sample was then imaged in buffer
using the liquid cell. Once a lipid layer was observed, 15 μl of 10 μM
peptide was injected and the resultant images were observed. Topo-
graphic, phase and amplitude images at a resolution of 512×512
were simultaneously obtained using scan frequencies between 0.5
and 1.5 Hz with typical scan sizes of 5 μm×5 μm, 2 μm×2 μm,
1 μm×1 μm or 500 nm×500 nm. Minimal force was used to reduce
the tip effect on the sample. Images were processed with plane ﬁtting
and some ﬂattening using WSxM 4.0 software [27].
3. Results
3.1. Secondary structure analysis
The secondary structure of kalata B1 was investigated by circu-
lar dichroism in buffer and in the presence of DMPC, DMPC/DMPG
(4:1), DMPC/DMPG/cholesterol (16:4:5), and DMPE and DMPE/
DMPG (4:1) liposomes. Fig. 2 shows the CD spectra of kalata B1
in buffer and in the presence of the different liposomes. In each
case, kalata B1 showed a mixture of secondary structures which
is consistent with previously reported CD studies [20,22]. Solubility
problems in DMPE precluded consistent spectra to be obtained for
this lipid (data not included). The main feature of both sets of
published data at wavelengths>200 nm is the broad minimum
centred at approximately 223 nm, which is very similar to the
spectra we present in Fig. 2. The difference between each lipid so-
lution occurs below 200 nm which we have found can be due to
light scattering of lipid mixtures. The peptide is predominately β-
sheet-like in buffer and in the presence of each of the different li-
posomes and the different lipid mixtures had little inﬂuence on
the structure.
3.2. Membrane binding properties
The real-time membrane binding interaction of kalata B1, D-kalata
B1 and G6A was investigated by SPR on DMPC, DMPC/DMPG (4:1),
DMPC/DMPG/cholesterol (16:4:5), and DMPE and DMPE/DMPG (4:1)
lipid layers. Five different concentration curves were obtained with
10, 20, 30, 40 and 50 μM to yield a series of sensorgrams shown in
Fig. 3.3.2.1. Kalata B1
Fig. 3 shows typical sensorgrams for the binding of kalata B1 to
the different membrane layers. Kalata B1 showed fast binding on
DMPC in the ﬁrst initial seconds of the injection, after which the as-
sociation rate slowed in a second phase of the association. There
was also a linear concentration-dependent increase in response.
The highest concentration (50 μM) reached a maximum response
of 300 RU. The dissociation was very fast, with most of the peptide
dissociating from the surface in the ﬁrst few seconds after comple-
tion of the injection. A small amount of peptide remained on the
surface at 600 s.
Kalata B1 had a similar response on DMPC/DMPG and DMPC/
DMPG/cholesterol, but the response was lower with a maximum
response of 200 and 150 RU respectively for the highest concen-
trations tested. The overall shape of the curves was similar, with
the same two-phase association and rapid dissociation with
only a small amount of peptide remaining on the DMPC/DMPGmem-
brane layer and no peptide remaining on the DMPC/DMPG/cholesterol
layer.
In contrast, kalata B1 had a very different response on lipid layers
containing DMPE compared to lipid layers containing DMPC. There
was a much greater response on DMPE, with the highest concentra-
tion (50 μM) reaching 2400 RU and on DMPE/DMPG reaching a
slightly lower maximum response of 1900 RU at 50 μM peptide. The
shape of the curves was also quite different compared to those on
the DMPC containing lipid layers. Although the peptide reached a
greater maximum response, the rate of association was slower. Ini-
tially, the 10 μM concentration bound quickly but reached equilibri-
um by the end of the injection. As the concentration increased, the
rate of association changed with the higher concentrations taking
longer to reach equilibrium, with the top concentrations failing to
reach equilibrium. The dissociation was also slow for the peptide on
the lipid layers containing DMPE, with a small amount of peptide
remaining on the surface after 600 s.
3.2.2. All D-kalata B1
Fig. 3 also shows typical sensorgrams for the binding of the all D-
kalata B1 peptide on the ﬁve different lipid layers. D-Kalata B1
showed similar binding to the all L-isomer on DMPC. There was a
fast initial interaction then a 2nd slower phase of association. This
2nd phase of the association was a little faster than that of kalata B1
on this lipid layer. There was also a linear concentration dependent
increase in response and the highest concentration (50 μM) bound
to 350 RU before a rapid dissociation on completion of the injection.
The curves reached dissociation equilibrium quickly with approxi-
mately 120 RU left on the surface after 600 s.
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Fig. 3. Typical SPR sensorgrams of kalata B1 (A–E), D-kalata B1 (F–J) and G6A (K–O) on the different lipid bilayer mixtures, DMPC (A, F, K); DMPC/DMPG (4:1) (B, G, L); DMPC/DMPG/
cholesterol (16:4:5) (C, H, M); DMPE (D, I, N); DMPE/DMPG (4:1) (E, J, O). Inset boxes are magniﬁed scale. Sensorgrams were obtained at 5 different peptide concentrations from 10 to
50 μM. Injectionswere 200 s (t=0–200 s) at 30 μl/min and then the peptidewas allowed to dissociate for a further 400 s (t=200–600 s) as buffer continued to ﬂow through the system.
2357K. Hall et al. / Biochimica et Biophysica Acta 1818 (2012) 2354–2361D-Kalata B1 showed similar results on DMPC/DMPG but there was
a slightly lower response. The highest concentration bound up to 200
RU with a similar two phase association before a rapid dissociation
again with very little remaining on the surface at 600 s. The results
of the peptide on the DMPC/DMPG/cholesterol layer are almost iden-
tical to that on the DMPC/DMPG layer but the response is slightly
lower. The highest concentration reached a maximum of 150 RU.
D-Kalata B1 showed a greater response on the lipids containing
DMPE, similar to L-Kalata B1 than the DMPC containing lipids. The
peptide bound quickly in the ﬁrst few seconds but then showed a
slower 2nd phase of association comparable to the slow phase on
the DMPC lipids. The dissociation was also slower, and the peptide
dissociated completely from the surface. The results were similar
again on DMPE/DMPG with a similar shaped association and dissoci-
ation to the sensorgrams for DMPE, but the response was lower with
the highest concentration binding up to 1250 RU.
3.2.3. Alanine substituted G6A
Fig. 3 shows typical sensorgrams for the alanine substituted G6A
analogue on the different model membrane layers. G6A showed a
similar binding proﬁle as the other two peptides on DMPC. There
was fast initial binding in the ﬁrst few seconds which then slowed
and levelled out to reach a response of 230 RU at 50 μM concentra-
tion. The dissociation was almost instantaneous with only a small
amount of peptide remaining on the surface in only a few seconds
after the end of injection.
The response was similar on DMPC/DMPG and DMPC/DMPG/
cholesterol layers with similar shaped curves. However, the response
was slightly lowerwith the 50 μMconcentration reaching amaximum
of 170 and 130 RU respectively. The same fast association and dissoci-
ation were also evident.
However, G6A showed a completely different interaction with the
membranes containing DMPE. In contrast to kalata B1 and the all-D
analogue which showed a large increase in response on DMPEcompared to the lipids containing DMPC, G6A did not show this
strong binding. The peptide interacted in a similar way with DMPE
as with the DMPC membranes with a fast initial binding and then a
slower association phase up to a maximum response of 200 RU on
DMPE and 150 RU on DMPE/DMPG with the 50 μM concentration.
G6A again showed a fast dissociation with no peptide remaining on
the surface after only a few seconds of dissociation.
3.2.4. Quantitative analysis of sensorgrams
Kinetic analysis of the sensorgrams shown in Fig. 3 was performed
via curve ﬁtting to the different models detailed previously [28–30].
Curve ﬁtting using the 1:1 Langmuir model, the two state model
and the heterogeneous model yielded moderate quality ﬁts for
DMPC, DMPC/DMPG and DMPC/DMG/cholesterol. However, signiﬁ-
cantly poorer ﬁts were observed for DMPE and DMPE/DMPG (results
not shown) for which the chi2 values were very high (>2000 RU),
which is a reﬂection of the changing shape of the sensorgrams with
increasing peptide concentration. Overall, it was not possible to
make quantitative conclusions about the relative changes in afﬁnity
based on this analysis across the different membrane systems. This
clearly demonstrates the complexity of the interaction, which may in-
volve different kinetic steps of surface binding, insertion and self-
association which preclude reliable determination of overall rate
and afﬁnity constants.
In order to allow a semi-quantitative comparison between the two
peptides, the RU at the end of the association phase (at 200 s) was
plotted against peptide concentration [28] and shown in Fig. 4 for
(a) L-kalata, (b) D-kalata and (c) G6A. While these plots illustrate a
shallow, linear dependence on concentration for the DMPC-
containing bilayers, there was a strong concentration dependence of
RU for the DMPE-containing bilayers. Moreover, there appeared to
be a non-linear dependence of RU on concentration between lower
and higher concentrations particularly for L-kalata between 40 and
50 μM on the DMPE-containing bilayers. These results suggest that
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2358 K. Hall et al. / Biochimica et Biophysica Acta 1818 (2012) 2354–2361the DMPE-bound kalata may facilitate a higher amount of kalata bind-
ing which leads to higher RU values observed at high kalata concen-
tration. It is also evident from Fig. 4 that the system does not
approach equilibrium or saturation.
3.3. Membrane morphology
The interaction of kalata B1 with membranes was also investi-
gated by atomic force microscopy on DMPC and DMPE membrane
layers to determine if it caused changes in membrane morphology.
Fig. 5A is an image of a large membrane patch of DMPC toward the
top left of the image and a smaller patch below it on a ﬂat mica
surface. A large open area of mica is on the right. The green bar
is the point at which a cross section proﬁle of the lipid layer was
taken. Following imaging of the bilayer to ensure the stability of
the deposited bilayer material following rinsing with buffer [31],
the proﬁle showed the lipid layer to be ~3.5 nm in height. 15 μlFig. 5. A series of AFM images of the effect of kalata B1 on DMPC. A) A model bilayer of DMPC
15 μl of 10 m M peptide was then injected immediately after this image. B) 12 min after inje
patch has changed again D) 64 min after injection, this is a higher resolution image. E) 76 m
87 min, more material can be seen. Cross section of the green bar shows that the deposited m
D–F. Vertical coloured scale is 8 nm.of 10 μM of kalata B1 was injected immediately following this
image. Fig. 5B corresponds to 12 min after injection. There was a
slight change in the shape of the large membrane patch, but was
not a signiﬁcant change. Fig. 5C is an image 32 min after injection.
The shape of the patch had changed further with a more angular
point where it had previously been more rounded. Fig. 5D corre-
sponds to an image of the surface 64 min after injection of peptide
with a higher resolution scan. The edges of the large membrane
patch are rougher than previous images. This effect is partially ex-
aggerated due to the higher resolution. Fig. 5E is a scan of the sur-
face 76 min after injection of kalata B1. Material was deposited on
the bare mica patch on the right hand side. Fig. 5F corresponds to
87 min after injection and more material had deposited on the
mica. The green bar corresponds to a cross section which shows
that the deposited material was a few nm in height. Overall, there
was no evidence of extensive changes in the DMPC morphology
by kalata B1.that is ~3.5 nm in height as seen by cross section at the top far right from the green bar.
ction, the shape of the large patch has altered slightly. C) 32 min, the shape of the large
in, material began to deposit on the mica surface on the right hand side of the image. F)
aterial on the mica was a few nm in height. Scale bar is 400 nm for A–C and 200 nm for
Fig. 6. A series of AFM images of the effect of kalata B1 on DMPE. A) Shows a multitude of DMPE bilayer patches that are ~5.5 nm in height from the cross section (green bar). 15 ml
of 10 mM peptide was then injected after this image. B) 12 min after injection, with no visible change. C) 23 min after injection. D) 44 min after injection, a small amount of material
was seen deposited between the bilayer patches. E) 578 min, the amount of material has increased. F) 79 min after injection, a higher resolution image. A large amount of material
was seen between the patches. A cross section can be seen on the right showing that the deposited material on the mica was a few nm in height. Scale bar is 300 nm for A–E and
200 nm for F. Vertical coloured scale is 13 nm.
2359K. Hall et al. / Biochimica et Biophysica Acta 1818 (2012) 2354–2361Fig. 6A is an image of multiple DMPE membrane patches on a ﬂat
mica surface that are ~5.5 nm in height as can be seen by the cross
section proﬁle from the green bar. 15 μl of 10 μM kalata B1 was
injected immediately after this image. Fig. 6B corresponds to 12 min
after injection with no change in morphology observed. Fig. 6C corre-
sponds to 23 min after injection and again no real change in morphol-
ogy was apparent. Fig. 6D is an image of the surface 44 min after
injection of kalata B1. A small amount of material had deposited in
between the membrane patches on the mica. Fig. 6E corresponds to
57 min after injection of peptide. A lot more material was observed
on the mica areas in between the DMPE patches. Fig. 6F is a higher
resolution scan of the surface 79 min after peptide injection. A lot of
soft material was observed in between the membrane patches. A
cross section (green bar) revealed that the material was a few nm
in height. Again there was no evidence of any extensive changes in
the DMPE membrane morphology by kalata B1.
4. Discussion
The cyclic backbone and cystine knot have made cyclotides very
attractive for molecular scaffold design applications. They are resis-
tant to thermal and chemical breakdown, and therefore have poten-
tial as a stable scaffold for antimicrobial peptide design. Kalata B1
has been reported to have antimicrobial activity [14,23] and has pre-
viously [31] been shown to interact with and disrupt membranes
[15,16], possibly by forming a self-associating multimeric species
[18]. The aim of this study was to further explore the membrane bind-
ing properties of kalata B1 and two analogues in order to gain further
insight into the mechanism of membrane binding and lysis.
The ﬁrst analogue contained all-D amino acids and although it ex-
hibits lower cytotoxic and nematocidal activity [32] to the native pro-
tein, both L- and D-kalata B1 disrupt the membrane of RBCs [22]. This
previous study thus demonstrated that a stereo-speciﬁc receptor is
not crucial for biological activity. The weaker activity of D-kalata B1
also correlated with a lower afﬁnity for phospholipids in modelmembranes, suggesting that both isoforms act via a similar mecha-
nism that is dependent onmembrane interaction [22]. The second an-
alogue has a single substitution of Gly for Ala at the 6th residue which
results in a dramatic loss of haemolytic and insecticidal activity [23].
This present study therefore investigated whether these differences
in activity are related to a change in membrane binding on different
model bilayers by SPR.
Kalata B1 adopted a predominately β-sheet like structure, similar
to previous results [20,33], and consistent with the three dimensional
structure established from NMR studies, showing that the peptide
contains a series of β-turns and loops and a distorted triple-
stranded β-sheet [19]. Kalata B1 retained this structure in buffer
and in the presence of different mixtures of liposomes, indicating
that it is a stable conformation and that the components of the lipid
mixtures do not dramatically affect the structure. Other CD studies
have also shown that the peptide is very resistant to conformational
changes: for example, attempts at thermal (up to 90 °C) and chemical
denaturation of kalata B1 revealed little change in the structure [20].
The membrane interaction of kalata B1 showed similar binding to
each PC containing mixture (DMPC, DMPC/DMPG (4:1) and DMPC/
DMPG/cholesterol (16:4:5)) (Figs. 3 and 4). The binding wasmoderate
on these lipids, with relative binding levels decreasing in the order
DMPC>DMPC/DMPG>DMPC/DMPG/cholesterol. However, the inter-
action with membranes containing DMPE was dramatically enhanced,
with kalata B1 showing a 3–10 fold increase in response compared to
membrane layers containing DMPC, and is consistent with results
obtained previously with palmitolyloleyl-phosphatidylcholine (POPC),
palmitolyloleyl-phosphatidylethanolamine (POPE) and palmitolyloleyl-
phosphatidylglycerol (POPG) mixtures [34]. The results suggest that
kalata B1 is able to bind theDMPE-containingmixtures and also partially
penetrate the bilayer, as evident from the slower dissociation and resid-
ual binding on these lipid mixtures. DMPE is zwitterionic, as is DMPC,
but has a relatively smaller head group which allows a tighter packing
of the membrane compared to DMPC (24) which in turn leads to a
more upright orientation of the head group. This change in head group
Fig. 7. A) Localization of the hydrophobic residues within kalata B1 that form a hydro-
phobic patch shown in green. B) Membrane penetrating residues as measured by NMR
[42] shown in dark blue. Images on the right are 180° relative to those on the left. C)
Schematic representation of a possible tetramer model of kalata B1. The blue regions
represent the hydrophobic surface patch known to be associated with membrane bind-
ing, and the yellow regions represent the hydrophilic face that is correlated with bioac-
tivity.
Modiﬁed from [23].
2360 K. Hall et al. / Biochimica et Biophysica Acta 1818 (2012) 2354–2361orientation has thus allowed kalata B1 to interactmore stronglywith the
membrane surface in both DMPE and DMPE/DMPG mixtures. It is
unlikely that the increased binding is due to increased electrostatic inter-
actions as kalata B1 has only one positively charged residue (Arg28) and
therefore has a lowpropensity to interact via strong electrostatic interac-
tions.Moreover, the addition of anionic DMPG to themixture resulted in
a small decrease in the amount of peptide bound. The Arg28 residue has
been previously shown to be critical for antimicrobial activity [14], and
might be essential for the initial stages of membrane binding through
electrostatic interactions. Other macrocyclic peptides such as circulin B
and cyclopsychotride have a cluster of three cationic residues and are
active against gram negative bacteria such as Escherichia coli whereas
kalata B1, which contains a single positive charge, is inactive, suggesting
that cationic residues are important for the cytolytic activity (14). This is
also consistent with a recent study on the membrane binding effects of
cycloviolacin O2, a cyclotide that has more positive charges (+3)
than kalata B1 and has higher afﬁnity for anionic lipids [35].
With such a dramatic difference in membrane binding of kalata B1
on DMPC- and DMPE-containing lipids, it might be expected that
there would be a substantial difference in the effect of kalata B1 on
the morphology of each lipid bilayer. However, this was not the
case, with kalata B1 interacting in a similar way on both lipid mix-
tures as imaged by AFM, suggesting that the mechanism of action of
this peptide is not likely to be mediated by general membrane disrup-
tion or a carpet-like mechanism. This result is consistent with a recent
report that used electrophysiology to demonstrate that kalata B1
forms pores upon binding to a range of phospholipid bilayers [17].
The pores were reported to measure 41–47 Å in diameter, which is
at the resolution limits of the AFM measurements.
The all D-kalata B1 peptide interacted in a similar way to the
L-peptide with a similar association, binding response and dissociation
on the lipids containing DMPC (Fig. 3). It also had the lowest binding
interaction with DMPC/DMPG/cholesterol, which could once again
be due to the membrane stabilizing effect of cholesterol inhibiting
binding. Interestingly, D-kalata B1 also showed the same high binding
selectivity for DMPE lipids (but with slightly lower levels). Although
the phospholipid mixtures are model membrane systems, a close
correlation of haemolytic effects with membrane afﬁnities for L and
D-kalata B1was previously observed [22]. The same study also demon-
strated that biological activity depends on peptide oligomerization at
the membrane surface, which determines afﬁnity for membranes by
modulating the association/dissociation equilibrium [22]. Overall,
the results of the present study conﬁrm that the binding interaction
and the binding selectivity for DMPE membranes is not a stereo-
speciﬁc interaction. Although it has been demonstrated that PE phos-
pholipids containing unsaturated acyl chains preferentially adopt a
hexagonal phase structure [36,37], fully saturated PE phospholipids
are known to adopt a lamellar structure [38]. Since we have utilised
DMPE in this study, it is most likely that the model membranes in
our study exist as a bilayer structure. Moreover, the preparation of
the DMPE liposomes yielded a clear solution upon lipid rehydration
and vortexing consistent with the formation of lamellar structure
rather than a hexagonal phase, which yields a cloudy solution. The
resultant DMPE lipid bilayers imaged in the AFM experiments also
conﬁrm the presence of bilayers of 5 nm in height (Fig. 6).
The G6A analogue also showed similar membrane binding to
L-kalata B1 and D-kalata B1 on the DMPC lipids, with the same relatively
weak interaction. However, in contrast to L-kalata B1 and D-kalata B1,
the G6A analogue did not show any substantial binding selectivity for
DMPE. This is a signiﬁcant result and suggests that the composition of
the surface topography in this region of kalata B1 plays an important
role in the membrane interaction. A previous NMR study showed that
the conformation of G6A was almost identical to kalata B1, conﬁrming
that this substitution does not inﬂuence the secondary structure [23].
However, while the overall structure of this analogue is nearly identical
to kalata B1, the biological activity is vastly different [23], suggestingthat Gly6 plays a more critical role in the biological activity via an effect
on the surface topography rather than via an overall effect on the struc-
ture of the peptide. A similar conclusion has been reached with other
disulﬁde rich peptides such as the α-conotoxins that have sequence
diversity while still maintaining a common three dimensional struc-
ture [39,40]. This suggestion is further supported by the observation
that linear versions of kalata B1 that have essentially the same structure
as the cyclic peptide but a different surface topography are inactive
[41].
Previous studies have suggested that a cluster of hydrophobic res-
idues that form a solvent exposed patch on kalata B1 mediates inter-
action with the membrane [19]. A closer examination of the
localization of the hydrophobic residues within kalata B1 as shown
in Fig. 7A, reveals that Gly6 is not located in this hydrophobic
‘patch’, but lies adjacent to it [23]. Recent spin labelled NMR studies
have also demonstrated that this surface exposed hydrophobic
patch forms the membrane binding face of kalata B1 with DPC mi-
celles [42] which includes Gly6 at the edge of this region as seen in
Fig. 7B. Studies using analytical ultracentrifugation have also shown
that kalata B1 forms tetramers in sodium phosphate buffer [18].
Moreover, the recent demonstration that kalata B1 forms pores [17]
suggests that speciﬁc oligomerization along with membrane binding
is vital for the activity of kalata B1. Regions that have been shown
to be critical to activity have been found to lie orthogonal to the hy-
drophobic regions of kalata B1 [23]. This would be consistent with a
self association model in which four molecules come together, with
the activity-inﬂuencing hydrophilic surfaces facing inward and the
hydrophobic surfaces oriented on the face of the tetramer [23] as
shown in Fig. 7C. It is possible that the Gly6 residue lies within a re-
gion that would affect the propensity for self association and muta-
tions of this reside may hinder the ability of kalata B1 to self
associate and thereby reduce membrane binding.
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L-Kalata B1 and D-kalata B1 show strong selectivity towards
DMPE-containing lipids compared to DMPC-containing membranes
but do not cause any signiﬁcant change in membrane morphology,
suggesting that the all-D analogue exerts its action via the same
mechanism as the all-L peptide. By comparison, the strong selectivity
for DMPE was totally eliminated in the G6A analogue, indicating that
the Gly6 residue has a signiﬁcant role in the selective membrane in-
teraction. Overall, this study demonstrates that a single amino acid
substitution, which renders kalata B1 inactive, has also signiﬁcantly
altered the membrane binding properties and might represent a crit-
ical step in the cytolytic mechanism of kalata B1. This ﬁnding thus has
implications in the design of novel selective antimicrobial peptides
which are non-toxic to the host organism.
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